retatrutide fda approval status 2024 What Are the New Weight Loss Medications? Retatrutide FDA Approval Status: July

However, caffeinated beverages have mild diuretic effects and should not be counted as equivalent to water

There should be no floaters, no cloudiness, and no visible particles

The mean reduction in body weight at 48 weeks was 24.2% in the 12-mg group the largest reduction observed to date in a Phase 2 trial of an anti-obesity medication. Jastreboff et al., New England Journal of Medicine, 2023 The Liver-Fat Result Beyond weight loss, retatrutide produced a result that surprised researchers: dramatic reductions in liver fat

If either applies, consulting a healthcare provider makes sense

Sofwave is different

In recent years, there has been an increasing body of evidence to suggest that GLP-1s are an effective treatment as a weight-loss medication